Douglas Mental Health University Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1881-01-01

Employees: 1K

Market Cap: -

Website: http://www.douglas.qc.ca

Clinical Trials

Maternal Adversity, Vulnerability and Neurodevelopment

Completed

Conditions: Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)
Infant Development
Infant Behavior

First Posted Date: 2018-02-15

Last Posted Date: 2020-05-27

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 630

Registration Number: NCT03434457

Locations: 🇨🇦
Douglas Mental Health University Institute, Verdun, Quebec, Canada

The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol

Phase 2

Completed

Conditions: Adjustment Disorders
Posttraumatic Stress Disorder
Trauma and Stressor Related Disorders

Interventions: Drug: Propranolol Pill

First Posted Date: 2017-05-12

Last Posted Date: 2022-12-19

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 84

Registration Number: NCT03151681

Locations: 🇨🇦
Douglas Mental Health University Institute, Montréal, Quebec, Canada

Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators

Phase 2

Conditions: Adjustment Disorders
Acute Stress Disorder
Trauma and Stressor Related Disorders
Post-traumatic Stress Disorders

Interventions: Drug: Propranolol Hydrochloride
Drug: Placebo

First Posted Date: 2017-05-12

Last Posted Date: 2021-06-18

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 64

Registration Number: NCT03152175

Locations: 🇨🇦
Douglas Mental Health University Institute, Montreal, Quebec, Canada

Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

Phase 1

Completed

Conditions: Dementia of the Alzheimer Type
Age-related Cognitive Decline
Mild Cognitive Impairment Due to Alzheimer Disease

Interventions: Drug: Probucol

First Posted Date: 2016-03-14

Last Posted Date: 2018-01-31

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 23

Registration Number: NCT02707458

Locations: 🇨🇦
Douglas Hospital Research Centre, Montreal, Quebec, Canada

Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia

Phase 2

Completed

Conditions: Alzheimer Disease
Cognitive Decline Due to Alzheimer Disease
Mild Cognitive Impairment Due to Alzheimer Disease

Interventions: Drug: Placebo
Drug: Naproxen

First Posted Date: 2016-03-09

Last Posted Date: 2017-08-01

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 200

Registration Number: NCT02702817

Locations: 🇨🇦
Douglas Hospital Research Centre, Montreal, Quebec, Canada

Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis

Not Applicable

Completed

Conditions: Psychosis
Social Phobia

Interventions: Behavioral: Group Computer assisted cognitive remediation therapy
Behavioral: Manualized group Cognitive-behavioral therapy (CBT) for social anxiety in first episode psychosis

First Posted Date: 2014-11-19

Last Posted Date: 2022-10-25

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 105

Registration Number: NCT02294409

Locations: 🇨🇦
Douglas Mental Health University Institute, Verdun, Quebec, Canada

Accelerated rTMS for Treatment-Resistant Major Depression

Phase 2

Completed

Conditions: Major Depressive Disorder

Interventions: Device: Accelerated HF-rTMS (Magstim Rapid 2 stimulator)

First Posted Date: 2014-04-29

Last Posted Date: 2014-10-06

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 20

Registration Number: NCT02125799

Locations: 🇨🇦
Douglas Mental Health University Institute, Montreal, Quebec, Canada

tDCS Applied to the OFC: Effects on Decision-Making and Impulse Control

Not Applicable

Completed

Conditions: Impulsive Behavior
Suicidal Impulses

Interventions: Device: Transcranial Direct Current Stimulation

First Posted Date: 2013-03-06

Last Posted Date: 2014-10-06

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 45

Registration Number: NCT01805401

Locations: 🇨🇦
Neuromodulation Research Clinic, Douglas Mental Health University Institute, Montreal, Quebec, Canada

Memory Reconsolidation Blockade for Treating Drug Addiction

Phase 2

Completed

Conditions: Substance Dependence

Interventions: Drug: Propranolol and memory reactivation
Drug: Placebo and memory reactivation

First Posted Date: 2012-07-06

Last Posted Date: 2017-05-15

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 17

Registration Number: NCT01634347

Locations: 🇨🇦
The Heritage Home Drug and Alcohol Rehabilitation Centre, Godmanchester, Quebec, Canada
🇨🇦
Douglas Mental Health University Institute, Montreal, Quebec, Canada

Repetitive Transcranial Magnetic Stimulation for Treating Resistant Bipolar Depression

Phase 2

Completed

Conditions: Bipolar Depression

Interventions: Device: Magstim Rapid2 Stimulator

First Posted Date: 2012-04-27

Last Posted Date: 2015-05-28

Lead Sponsor: Douglas Mental Health University Institute

Target Recruit Count: 8

Registration Number: NCT01586793

Locations: 🇨🇦
Neuromodulation Research Clinic, Douglas Mental Health University Institute, Verdun, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy